Tag: Mutations

$Dizal Submits New Drug Software to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Most cancers with EGFR Exon 20 Insertion Mutations 2$

Dizal Submits New Drug Software to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Most cancers with EGFR Exon 20 Insertion Mutations

November 8, 2024